Company Filing History:
Years Active: 2023
Title: Inventor Adriaan Verhelle: Pioneer in PCR-based Epigenetic Age Prediction
Introduction
Adriaan Verhelle is an innovative inventor based in San Diego, CA, specializing in cutting-edge research that bridges biology and technology. With a keen focus on epigenetic age prediction, he has contributed to a transformative field that holds promising implications for healthcare and aging research.
Latest Patents
Adriaan Verhelle holds a patent for a method related to PCR-based epigenetic age prediction. This method involves the systematic process of generating epigenetic age predictions through a series of steps that include providing a sample extraction test kit, extracting DNA from a sample, and amplifying specific loci to obtain methylation values for CpG sites. This innovative approach represents a significant advancement in predicting biological age, which can offer valuable insights into health and aging.
Career Highlights
Verhelle's career has been marked by his role at H42, Inc., where he has been instrumental in developing methods that utilize PCR technology for epigenetic analysis. His work not only enhances the understanding of gene expression but also contributes to the broader field of epigenetics, enabling new studies and applications in medical research.
Collaborations
Throughout his career, Adriaan has collaborated with notable colleagues including Sandra Ann R Steyaert and Geert Trooskens. These collaborations exemplify his commitment to teamwork in advancing scientific knowledge and ensuring that innovative solutions are realized effectively within the industry.
Conclusion
Adriaan Verhelle continues to push the boundaries of innovation within the field of epigenetics. His groundbreaking patent on PCR-based epigenetic age prediction highlights the intersection of science and technology, paving the way for future discoveries that could profoundly influence healthcare and our understanding of aging.